Despite the significant disease burden, Myalgic encephalomyelitis (ME), previously known as chronic fatigue syndrome (CFS), lacks effective diagnostics and therapeutics. Emily Taylor, President and CEO of Solve M.E., explains why dedicated research for Infection-Associated Chronic Conditions and Illnesses (IACCIs) such as ME/CFS is vitally needed.
Long-term COVID-19 effects have been decreased from anywhere between 50 and 80% for those who have been vaccinated when compared to unvaccinated people.
One in eight adults (12.7%) who are infected with SARS-CoV-2 experience long COVID symptoms, including chest pain, difficulties breathing, painful muscles and more.
According to a US review of Long COVID patients, 30.7% of these people had no existing comorbidities that could explain their susceptibility to the virus.
Having lifted most of its COVID regulations – spikes in infections show that UK herd immunity through vaccination programmes is not efficient in the long run.
The STIMULATE study will assess how patients with Long Covid progress and recover, explore innovative treatment options and investigates health inequalities
